|
Covance is pleased to announce the availability of two new monoclonal antibodies specific to the E4 isoform of apolipoprotein E (Apo-E4). The addition of Apo-E4 clones 9D11 and 5G7 adds to Covance's growing portfolio of key products available for neurodegenerative disease research.
|